フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
GSK PLC's annual results, guidance lift and buyback announcement lifted the stock and helped gloss over worries for i ...
GSK PLC on Wednesday raised its long-term sales guidance and announced a GBP2 billion share buyback, reflecting optim ...
GSK PLC 05 February 2025 GSK delivers strong 2024 performance with further improvement to long-term growth outlook Strong sales and Core EPS...
Both GSK PLC and markets expect the firm to report increased earnings for 2024 - but analysts remain concerned by geo ...
GSK PLC 03 February 2025 GSK plc Total Voting Rights and Capital In conformity with the Financial Conduct Authority's Disclosure Guidance...
GSK PLC on Tuesday said applications for its treatment for a type of asthma and chronic rhinosinusitis with nasal pol ...
GSK PLC 28 January 2025 Issued: 28 January 2025 London UK Depemokimab applications accepted for review in China and Japan for asthma with...
GSK PLC 28 January 2025 Issued: 28 January 2025 London UK Depemokimab accepted for review by the European Medicines Agency for use in asthma...
Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease fro ...
GSK PLC on Monday said the European Medicines Agency accepted for review its application for an alternative treatment ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
サインアップして広告なしのエクスペリエンスを体験してください
今すぐ試してください
広告を残す